NDC 70518-1192-01 - ALENDRONATE SODIUM
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-1192
- Requested NDC
- 70518-1192-01
- Package NDCs from labels
- 70518-1192-0, 70518-1192-1, 70518-1192-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-07-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ALENDRONATE SODIUM - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-07-03 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-1192-0 | ALENDRONATE SODIUM | 4 in 1 BLISTER PACK | TABLET | 4 | 7 | |
| 70518-1192-1 | ALENDRONATE SODIUM | 4 in 1 BLISTER PACK | TABLET | 4 | 7 | |
| 70518-1192-1 | ALENDRONATE SODIUM | 3 in 1 CARTON | TABLET | 3 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-1192 | ALENDRONATE SODIUM TABLET [REMEDYREPACK INC.] | 3 | Current NDC, 3 package rows | 20250508_c7e470d6-508e-466e-a78d-060bbbc9745c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | A-S Medication Solutions | fe1dd324-eb02-4a73-97f5-9b77a7df10a7 | 2025-12-05 | Warnings, Adverse reactions | ANDA076768 904431 2UY4M2U3RA |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Alendronate Sodium | ALENDRONATE SODIUM | ANI Pharmaceuticals, Inc. | 81589178-10c9-4806-91eb-54e638d35b8d | 2025-10-29 | Warnings, Adverse reactions | 2UY4M2U3RA |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Alendronate | ALENDRONATE SODIUM TABLET | Marlex Pharmaceuticals, Inc. | b63421af-ec03-1de7-e053-2a95a90abec6 | 2025-09-10 | Warnings, Adverse reactions | 904396 904431 2UY4M2U3RA |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | NuCare Pharmaceuticals, Inc. | 2baf8516-4148-9007-e063-6394a90a8094 | 2025-01-14 | Warnings, Adverse reactions | ANDA076768 904431 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | A-S Medication Solutions | 873442b0-1932-4fa6-ba25-b4d3505f4128 | 2024-11-13 | Warnings, Adverse reactions | 904396 2UY4M2U3RA |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| MANNITOL | MANNITOL | HF Acquisition Co LLC, DBA HealthFirst | 999ce711-2d5b-0d7d-e053-2995a90a2689 | 2024-01-27 | Warnings, Adverse reactions | 3OWL53L36A |
| ALENDRONATE SODIUM | ALENDRONATE SODIUM | EXELAN PHARMACEUTICALS INC. | 91a0f73a-d8cd-4197-b431-40707a2150b9 | 2023-08-25 | Warnings, Adverse reactions | ANDA076768 904396 904431 2UY4M2U3RA |
| Mannitol | MANNITOL | B. Braun Medical Inc. | d12cc802-b538-4065-a264-f474ff3b3043 | 2023-08-15 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Fresenius Kabi USA, LLC | c395e13d-6ea1-4104-8b37-669cfb982f04 | 2023-03-16 | Warnings, Adverse reactions | 3OWL53L36A |
| Alendronate Sodium | ALENDRONATE SODIUM | Proficient Rx LP | 6c4d13fb-490c-4ea9-9b04-003c8d8e9f0c | 2023-03-01 | Warnings, Adverse reactions | 904431 2UY4M2U3RA |
| Alendronate Sodium | ALENDRONATE SODIUM | Amneal Pharmaceuticals of New York LLC | c23fb7fe-c6b9-4f77-bde7-992222b589d3 | 2021-02-02 | Warnings, Adverse reactions | 904396 904431 2UY4M2U3RA |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.